JUSTIN FRYE: Open Payments
NPI 1750930467 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 24 payments from 10 companies in 2025. Trend: 2023 $809 · 2024 $518 · 2025 $455
Food & beverage: $446Education: $9
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 10 | $120 |
| Novartis Pharmaceuticals Corporation | 3 | $87 |
| SCPHARMACEUTICALS INC. | 3 | $67 |
| Vifor Pharma, Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Fresenius USA Marketing, Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| OPKO Pharmaceuticals, LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Vanrafia, FUROSCIX, Veltassa, JYNARQUE, VELPHORO, Kerendia, RAYALDEE, FARXIGA.
Industry payments across FL — which companies pay providers there.
